AAD consensus statement on psoriasis therapies

Journal of the American Academy of Dermatology

Volumn 49, Issue 5, 2003, Pages 897-899

  Callen, Jeffrey P ^a   Krueger, Gerald G ^b   Lebwohl, Mark ^b   McBurney, Elizabeth I ^b   Mease, Philip ^b   Menter, Alan ^b   Paller, Amy S ^b   Pariser, David M ^b   Weinblatt, Michael ^b   Zimmerman, Gail ^b  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALEFACEPT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EFALIZUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; KERATOLYTIC AGENT; LUBRICATING AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; RETINOID; SALAZOSULFAPYRIDINE; TAR; TAZAROTENE; VITAMIN D DERIVATIVE;

AGE; CONFERENCE PAPER; DISEASE SEVERITY; HUMAN; LABORATORY TEST; MEDICAL SOCIETY; ORGANIZATION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SKIN BIOPSY; SYMPTOMATOLOGY;

EID: 0142151699     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)01870-X     Document Type: Conference Paper

References (7)

1. Gladman DD. Psoriatic arthritis. Rheum Clin North Am 1998;24:829-44.
2. Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? what constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000;43:281-5.
3. Lebwohl M, Feldman SR, Koo JYM, Menter A. Psoriasis: treatment options and patient management. Portland (OR): National Psoriasis Foundation; 2002.
4. Mease PJ. Psoriatic arthritis/psoriasis. In: Smolen JS, Lipsky PE, editors. Targeted therapies in rheumatology. London: Martin Dunitz; 2003. p. 525-48.
5. Menter A, editor. Psoriasis for the clinician: a new therapeutics era (“the Biologics”) beckons. J Am Acad Dermatol 2003;49(Suppl):S39-142.
6. Menter A, Bagel J, Feldman SR. Practice management considerations for biologic therapies. Portland (OR): National Psoriasis Foundation; 2002.
7. Weinstein GD, Gottlieb AB. Therapy for moderate-severe psoriasis. Portland (OR): National Psoriasis Foundation; 2003.